Lipoprotein (a) Screening, and What's Next? Cover

.blurhash-client-img { display: none !important; }

Lipoprotein (a) Screening, and What's Next?

Journal of Cardiovascular Emergencies

Volume 10 (2024): Issue 4 (December 2024)

By: Anna Pasławska, Agnieszka Radom and Przemysław Tomasik

Open Access

|Dec 2024

Authors

Anna Pasławska

Centrum Zdrowia Tuchów sp. z o.o., Medical Diagnostic Laboratory, Poland

Agnieszka Radom

Diagmed sp. z o.o., Medical Diagnostic Laboratory, Poland

Przemysław Tomasik

p.tomasik@uj.edu.pl

Department of Clinical Biochemistry, Institute of Pediatrics, Jagiellonian University Medical College, Kraków, Poland

DOI: https://doi.org/10.2478/jce-2024-0022 | Journal eISSN: 2457-5518 | Journal ISSN: 2457-550X

Journal RSS Feed

Language: English

Page range: 142 - 150

Submitted on: Sep 16, 2024

|

Accepted on: Nov 11, 2024

|

Published on: Dec 26, 2024

Published by: Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

lipoprotein (a),

apolipoprotein (a),

cardiovascular diseases,

atherosclerosis,

lipid disorders

Related subjects:

Clinical medicine,

Internal medicine,

Emergency medicine and intensive-care medicine,

© 2024 Anna Pasławska, Agnieszka Radom, Przemysław Tomasik, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 10 (2024): Issue 4 (December 2024)Next article